Mustang Bio Inc (NASDAQ: MBIO) closed the day trading at $0.52 down -23.14% from the previous closing price of $0.68. In other words, the price has decreased by -$0.1644 from its previous closing price. On the day, 1039248 shares were traded.
Ratios:
For a better understanding of MBIO, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.74 and its Current Ratio is at 0.74. In the meantime, Its Debt-to-Equity ratio is 20.83 whereas as Long-Term Debt/Eq ratio is at 16.50.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on May 18, 2021, initiated with a Buy rating and assigned the stock a target price of $11.
On October 02, 2020, B. Riley FBR started tracking the stock assigning a Buy rating and target price of $9.
On November 20, 2019, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $7.Cantor Fitzgerald initiated its Overweight rating on November 20, 2019, with a $7 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MBIO now has a Market Capitalization of 7.02M and an Enterprise Value of 3.29M. Its current Enterprise Value per Revenue stands at -1.32k whereas that against EBITDA is -0.07.
Stock Price History:
Over the past 52 weeks, MBIO has reached a high of $8.17, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is 1.1760, while the 200-Day Moving Average is calculated to be 2.3332.
Shares Statistics:
Over the past 3-months, MBIO traded about 160.69K shares per day on average, while over the past 10 days, MBIO traded about 155.83k shares per day. A total of 8.37M shares are outstanding, with a floating share count of 7.65M. Insiders hold about 27.02% of the company’s shares, while institutions hold 10.40% stake in the company. Shares short for MBIO as of Mar 15, 2024 were 389.03k with a Short Ratio of 1.11, compared to 42.68k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 3.74% and a Short% of Float of 5.18%.
Earnings Estimates
Current recommendations for the stock of the company come from 1 analysts. On average, analysts expect EPS of -$0.87 for the current quarter, with a high estimate of -$0.87 and a low estimate of -$0.87, while EPS last year was -$2.06. The consensus estimate for the next quarter is -$0.88, with high estimates of -$0.88 and low estimates of -$0.88.
Analysts are recommending an EPS of between -$3.57 and -$3.57 for the fiscal current year, implying an average EPS of -$3.57. EPS for the following year is -$5.04, with 1 analysts recommending between -$5.04 and -$5.04.
